ALKERMES | ALKS - 営業経費





営業経費 変化する 日付
AbbVie USD 10.27B 1000K 2026-06
Acadia Pharmaceuticals USD 272.68M 6.08M 2026-03
ALKERMES USD 1.81B 57.02M 2026-06
Amgen USD 4.78B 1.12B 2026-03
Biogen USD 2.98B 1.02B 2026-06
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Coherus Biosciences USD 51.83M 2.48M 2025-12
Eli Lilly USD 10.02B 285M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
Heron Therapeutics USD 40.55M 1.46M 2025-12
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
J&J USD 17.83B 388M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
Merck USD 18.17B 8.01B 2026-03
Minerva Neurosciences USD 4.52M 155.46K 2024-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Neurocrine Biosciences USD 739.1M 139.2M 2026-06
Otsuka Holdings JPY 561.64B 49.51B 2026-06
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pfizer USD 90.1B 77.19B 2026-03
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03